CPA
PGNX

Cowen Prime Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Cowen Prime Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500
Closed -$3K – 257
2015
Q4 		$3K Sell
500
-37,500
-99% -$225K ﹤0.01% 204
2015
Q3 		$217K Hold
38,000
– – 0.1% 97
2015
Q2 		$283K Buy
+38,000
New +$283K 0.11% 87